Classifieds

Please send us your submissions for Classifieds using the form below, this column.

 

Classified Positions Available

ST. PETER'S HOSPITAL, a member of St. Peter’s Health Partners, located in Albany, NY, is seeking a full time Addiction Medicine physician to join its established and respected team. The position provides inpatient addiction medicine (detoxification/rehabilitation) and medical management services in our 18 bed inpatient unit with midlevel provider support.  

Candidates should be board certified in IM/FP and possess at least one year of direct experience with addiction medicine. Certification in the administration of Suboxone is required. ASAM/ABAM certification is strongly preferred and will be required within one year of hire if not already obtained.  

The position offers a competitive salary and benefits package including: health/vision/dental, paid malpractice, 30 days paid leave annually with carry over and buy out options, CME allowance & dedicated time off, 403(b) and cash pension programs.

Albany is a medium sized city offering all the amenities of a larger city in a beautiful, scenic, and affordable setting. Albany has excellent year-round outdoor recreation, including great golf, water-sports, camping, hiking, and great skiing. Albany offers a wealth of cultural offerings and activities, including several renowned museums and theaters, fine dining, and a year-round events calendar of music and sporting events. Excellent public and private schools are available, as are affordable homes and reasonable taxes. Albany is a short drive from beautiful Saratoga Springs, the scenic Adirondack, Berkshire, and Catskill Mountains, and is part of New York’s Historic Hudson and Mohawk Valleys. Centrally located, Albany is less then three hours from New York City and Boston.

Find out more and apply online at www.sphcs.org

These are not  J-1 or H1-B opportunities

This form does not yet contain any fields.

    Member News

    Please send us your submissions for Member News using the form below, right column.

    NYSAM News

    Tuesday
    Feb182014

    Overview of Opioid Overdose Prevention Programs in New York State

     

    Opioid overdose is a significant problem across the country including New York State. Widespread misuse of prescription opioids and heroin continues to be a serious problem.  One tool in preventing opioid overdose morbidity and mortality is increasing access to naloxone.

    Naloxone (Narcan) is a prescription medicine that reverses an overdose by blocking heroin or other opioids in the nervous system for 30 to 90 minutes. Naloxone is administered by injection or intranasally. It is successfully prescribed and distributed to opioid users, their families and friends in at least 19 states.  Thousands of individuals participating in these programs have safely and successfully reversed overdoses. As of the end of 2010 over 50,000 people in the United States had received naloxone kits and over 10,000 overdose reversals had been reported. 

    A new life-saving law took effect in 2006, making it legal in New York State for non-medical persons to administer naloxone to another individual to prevent an opioid/heroin overdose from becoming fatal.  The New York State Department of Health (NYSDOH) registers eligible agencies and providers to operate an Opioid Overdose Prevention Program and provides the required supplies for free.  These programs train individuals how to respond to suspected overdoses including the administration of naloxone, which is provided free as part of the training.

     Requirements:

    • Registration with the NYSDOH authorizes physicians, Nurse Practitioners and Physician
      Assistants to prescribe naloxone to people at risk of witnessing an overdose and authorizes an agency (or individual clinician) to order free intramuscular naloxone kits from the NYSDOH.
    • Each opioid overdose program must have a program director and a clinical director who are responsible for complying with the program requirements and insuring the quality of the training performed by the agency.  The clinical director must be an MD, PA, or NP.  Agencies that do not have medical providers on staff may hire someone for this function for a limited number of hours. 
    • Sample policy and procedures are available to simplify integration into an agencies existing policy and procedures.
    • Any competent staff member or volunteer can do the training on overdose prevention and response; the prescribing clinician need not be present. Train the Trainer sessions are available as is an educational curriculum.
    • Naloxone is a prescription medication, thus governed by NYS prescribing regulations.  The prescribing clinician must have a face to face encounter with each recipient, provide a prescription (serving as a label) and a record of the recipients identifying information as well as a note that the recipient has been trained.  This can be done in less than a minute. Prescription medications may only be dispensed by a licensed prescriber, nurse or pharmacist.
    • Agencies in New York City may register with the New York City Department of Health and Mental Hygiene in order to be eligible to order free intranasal naloxone kits.

    Implementation varies among agencies according to their needs and settings (syringe access programs, drug treatment programs, primary care, in-patient hospital units, etc.).  Trainings can be tailored to individuals, groups, or classrooms, and may vary in length from 10 - 50 minutes.  A 12 minute DVD can be used supplemented by hands on demonstration.

    The Harm Reduction Coalition works under contract with the NYSDOH to provide assistance in implementing opioid overdose prevention programs. We can help by training staff, discussing the application for NYSDOH registration, and helping to determine training needs of staff and clients.  

    Contact the Harm Reduction Coalition: for more information and assistance in establishing an overdose prevention program:

    Sharon Stancliff, MD: Stancliff@harmreduction.org 
    (212) 213-6376 ext 39

    Bill Matthews, RPA-C: Matthews@harmreduction.org
    (212) 213-6376 ext 38

    Overdose prevention resources

    Harm Reduction Coalition

    http://wwwHarmreduction.org

    Many resources under “Overdose”


    New York State Department of Health

    http://www.health.state.ny.us/diseases/aids/harm_reduction/opioidprevention/index.htm

    Includes sample curriculum, policy & procedures, a list of registered agencies


    New York City Department of Health and Mental Hygiene

    http://www.nyc.gov/html/doh/html/basas/od-provider.shtml

     

    The NYCDOH&MH training video is easily seen here:

    http://vimeo.com/4495088

     

    Testimonials

    http://harmreduction.org/issue-area/overdose-prevention-issue-area/i%E2%80%99m-the-evidence-video/

     

     

     

    Tuesday
    Oct152013

    Do You Want to Learn More About Managing Chronic Opioid Therapy and Addiction? Participate in This NIH-Funded Research Study 

    RESEARCH STUDIES

    Inflexxion® develops behavioral change programs that reduce health-related risks, improve clinical outcomes and positively influence quality of care and improve public health. Please choose the research study that interests you and click the corresponding link for more information. If you are eligible for a study a Research Coordinator will contact you. If you have questions about these studies, or would like to speak with someone, please call 617-332-6028 anytime Monday through Friday 9:00am to 5:00pm EST.

    Current Studies:

    MAP-PC Field Trial

    Do you want to learn more about managing chronic opioid therapy and addiction?

    Participate in our NIH-Funded research study!

    This study is being funded by the National Institutes of Health (NIH) and will evaluate knowledge, behaviors, and attitudes about managing chronic pain and addiction in a primary care setting. We are currently looking for physicians, residents, fellows, nurses, nurse practitioners or physician assistants who are currently practicing in a primary care setting, and are a currently-licensed prescriber of prescription pain medications.  Participants will complete one of two online programs focused on provider management of chronic non-cancer pain with chronic opioid therapy. Participants will take approximately 4 hours to complete the online course on their own at times and locations of their convenience.   

    WHY PARTICIPATE?

    Opioid management is a challenging area of primary care.  With new requirements for education on the horizon, there is increasing need for providers to be knowledgeable in this area. The online programs in this study teach ways to efficiently and effectively manage pain care by:

    Assessing  and managingdifficult patients

    Identifying appropriate patients for referral

    Maximizing medical team resources

    Enhancing patient compliance with treatment and monitoring regimens

     

    Participants will receive an honorarium of up to $300 if they complete all study tasks.

    Feel free to invite your colleagues to participate in this study!

    If you are interested in participating in the study, please click the following link to learn more.

    If you have any questions, please contact the research coordinator, Cristina Los, atMAPPCstudy@inflexxion.com or 617-775-7873.
    Tuesday
    Oct152013

    Reasons for Misuse of Prescription Medication Among Physicians Undergoing Monitoring by a Physician Health Program

    Journal of Addiction Medicine:
    doi: 10.1097/ADM.0b013e31829da074
    Original Research

    Merlo, Lisa J. PhD, MPE; Singhakant, Supachoke MD; Cummings, Simone M. PhD, MHA; Cottler, Linda B. PhD, MPH

    Abstract

    Objectives: Substance-related impairment of physicians is a small but serious problem, with significant consequences for patient safety and public health. The purpose of this study was to identify reasons for prescription drug misuse among physicians referred to a physician health program for monitoring because of substance-related impairment, to develop better mechanisms for prevention and intervention.

    Methods: A total of 55 physicians (94.5% male) who were being monitored by their State physician health program because of substance-related impairment participated in guided focus group discussions. Participation was anonymous. Discussions were transcribed from 9 separate focus groups, lasting 60 to 90 minutes each. Qualitative analyses were conducted to examine themes.

    Results: All participants were diagnosed with substance dependence, and 69.1% of them endorsed a history of misusing prescription drugs. Participants documented the following 5 primary reasons for prescription drug misuse: (1) to manage physical pain, (2) to manage emotional/psychiatric distress, (3) to manage stressful situations, (4) to serve recreational purposes, and (5) to avoid withdrawal symptoms.

    Conclusions: Our results emphasize the importance of self-medication as a leading reason for misusing prescription medications, although recreational use was also an important factor. Prevention efforts targeting prescription drug misuse among physicians should be initiated during medical training, with continuing education requirements throughout the physicians’ careers.

    To access the full article, please click here.

    Tuesday
    Oct152013

    Report: States not hooked on programs to solve prescription addiction and overdose deaths

    A new scorecard of how states are adopting tactics to reduce prescription drug addiction and overdose deaths concludes that many have not fully embraced some key tools.

    Only two states – New Mexico and Vermont – have adopted all 10 laws and policies considered helpful toward ending an epidemic that affects at least 6 million people, according to the survey released Monday by the non-profit Trust for America’s Health.

    “This requires a combined approach, there isn’t a magic bullet solve this problem,’’ said Jeff Levi, executive director of the group.

    With 50 Americans dying from prescription drug overdoses every day and with just 10 percent of people battling addiction getting treatment, “This is a very real epidemic, and warrants a strong public health response. We must use the best lessons we know from other public health and injury prevention success stories,’’ said Andrea Gielen, director of the Johns Hopkins Center for Injury Research and Policy.

    (Tennessee has the eighth highest drug overdose mortality rate in the United States, with 16.9 per 100,000 people suffering drug overdose fatalities. The number of drug overdose deaths - a majority of which are from prescription drugs - has doubled in Tennessee since 1999.)

    Among the findings:

    All but one state – Missouri – have a prescription drug monitoring program that can help identify “doctor-shopping” patients, problem prescribers and people with addiction problems. But only 16 states require all medical providers to use the systems.

    And while 44 states allow prescribing information to be shared with providers in neighboring states, patient drug histories are not automatically shared – doctors and others must ask for the information. Levi said the prescription records would be more easily shared and helpful if they could be merged with electronic patient health records, but that those systems, while growing, are still far from complete.

    Fewer than half the states –22 – have laws that require special addiction prevention education for doctors and others who prescribe prescription pain medication.

    Only 32 states have laws requiring or permitting a pharmacist to see photo identification of a patient before dispensing a controlled drug.

    Just over a third of the states – 17 – have laws providing some immunity from prosecution for individuals seeking help for themselves or others experiencing an overdose. The same number have a law in place to allow non-professionals access and use of naxolone – a prescription drug that can be used to counteract an overdose.

    The entire report on strategies and state-by-state data and rankings can be found at http://www.tfah.org/reports/drugabuse2013/

    Tuesday
    Sep102013

    Substance Abuse Mental Health Services Administration Awards $3 Million Grant to Educate Physicians on Evidence-Based Approaches to Medication-Assisted Treatment for Opioid Dependence

    CHEVY CHASE, MD, (September 10, 2013)

     

    The Center for Substance Abuse Treatment/Substance Abuse and Mental Health Services Administration has awarded a three-year grant, "Physician Clinical Support System for Medication Assisted Treatment (PCSS-MAT)," to the American Academy of Addiction Psychiatry (AAAP) effective August 1, 2013.  The American Society of Addiction Medicine (ASAM) is proud to announce that they will join the collaborative effort led by AAAP which also includes the American Osteopathic Academy of Addiction Medicine (AOAAM) and the American Psychiatric Association (APA).  Collectively these organizations bring together a wealth of experience and expertise that will enhance and extend the work in addressing this public health priority.  The Association for Medical Education and Research in Substance Abuse (AMERSA), an affiliated partner, will expand the reach to nurses, social workers and pharmacists.

    AAAP has recruited many national professional organizations from primary care and a wide array of other fields, including but not limited to: pain medicine, pharmacists, neurologists, obstetricians and nurses to be members of PCSS-MAT Steering Committee. The Steering Committee will help with outreach and development of educational resources tailored to meet the needs of their constituents.

    "ASAM is honored to be working alongside the leading addiction organizations to provide free resources to train clinicians, program directors, and the public about the evidence-based treatments for opioid addiction," says Dr. Alford who will serve as ASAM's Clinical Director and Clinical Expert.  "These resources will be a great benefit to our members and the larger field of addiction medicine professionals," adds Stuart Gitlow, MD, ASAM President.

    The educational resources and training developed by the project will include: 1) clinical online modules, 2) case vignettes, 3) webinars, 4) live trainings, 5) mentor program and 6) clinical tools to assist practicing clinicians. These resources will be provided free of charge on the PCSS-MAT website, www.pcssmat.org which will be launched in early Fall 2013.

    Funding for this initiative was made possible (in part) by Physicians' Clinical Support System for Medication Assisted Treatment (1U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    The American Society of Addiction Medicine is a national medical specialty society representing over 3,000 physicians and associated professionals. Its mission is to increase access to and improve the quality of addiction treatment, to educate physicians, and other health care providers and the public, to support research and prevention, to promote the appropriate role of the physician in the care of patients with addictive disorders, and to establish Addiction Medicine as a specialty recognized by professional organizations, governments, physicians, purchasers and consumers of health care services and the general public. ASAM was founded in 1954, and has had a seat in the American Medical Association House of Delegates since 1988.